Victoza (liraglutide) was approved June 17, 2019, for pediatric patients 10 years of age and older for the treatment of type 2 diabetes. This is the first non-insulin drug approved to treat type 2 diabetes in children since metformin was approved for pediatric patients in 2000.
Disclaimer
Disclaimer This website is owned and operated by a private individual and is intended solely for informational and educational purposes. The website does not constitute a medical provider, healthcare entity, business organization, or commercial service, Read more
